Archive of Postings to PHARM-POLICY

  This is a small "discussion" list which discusses issues relating
  to pharmaceutical development.  The issues of particular interest
  to PHARM-POLICY subscribers are pharmaceutical drug pricing, the
  federal government's "reasonable pricing" clause for government
  developed drugs, the GATT Intellectual Property provisions as
  they relate to compulsory licensing and other similar issues.
  Subscription requests to pharm-policy are by electronic mail, sent 
  to, with the message:
  subscribe pharm-policy yourfirstname yourlastname

[ Go to the Index of all Archived Lists ]

[ Go to the Index of all Archived Lists ]
[Prev Page][Next Page]

Mail converted by MHonArc 2.3.3